Cargando…
P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430633/ http://dx.doi.org/10.1097/01.HS9.0000969988.77790.3c |
| _version_ | 1785091012967792640 |
|---|---|
| author | Wook Lee, Jong Griffin, Morag Seok Kim, Jin Wong, Lily L L Piatek, Caroline Jain, Deepak Liu, Peng Filippov, Gleb Sicre de Fontbrune, Flore Maria Risitano, Antonio Kulasekararaj, Austin |
| author_facet | Wook Lee, Jong Griffin, Morag Seok Kim, Jin Wong, Lily L L Piatek, Caroline Jain, Deepak Liu, Peng Filippov, Gleb Sicre de Fontbrune, Flore Maria Risitano, Antonio Kulasekararaj, Austin |
| author_sort | Wook Lee, Jong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104306332023-08-17 P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO Wook Lee, Jong Griffin, Morag Seok Kim, Jin Wong, Lily L L Piatek, Caroline Jain, Deepak Liu, Peng Filippov, Gleb Sicre de Fontbrune, Flore Maria Risitano, Antonio Kulasekararaj, Austin Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430633/ http://dx.doi.org/10.1097/01.HS9.0000969988.77790.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Wook Lee, Jong Griffin, Morag Seok Kim, Jin Wong, Lily L L Piatek, Caroline Jain, Deepak Liu, Peng Filippov, Gleb Sicre de Fontbrune, Flore Maria Risitano, Antonio Kulasekararaj, Austin P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title | P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title_full | P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title_fullStr | P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title_full_unstemmed | P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title_short | P771: PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND CLINICALLY SIGNIFICANT EXTRAVASCULAR HEMOLYSIS ON RAVULIZUMAB/ECULIZUMAB SHOWED HEMOGLOBIN RESPONSE SUPERIORITY WITH ADD-ON DANICOPAN VS PLACEBO |
| title_sort | p771: patients with paroxysmal nocturnal hemoglobinuria and clinically significant extravascular hemolysis on ravulizumab/eculizumab showed hemoglobin response superiority with add-on danicopan vs placebo |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430633/ http://dx.doi.org/10.1097/01.HS9.0000969988.77790.3c |
| work_keys_str_mv | AT wookleejong p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT griffinmorag p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT seokkimjin p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT wonglilyll p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT piatekcaroline p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT jaindeepak p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT liupeng p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT filippovgleb p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT sicredefontbruneflore p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT mariarisitanoantonio p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo AT kulasekararajaustin p771patientswithparoxysmalnocturnalhemoglobinuriaandclinicallysignificantextravascularhemolysisonravulizumabeculizumabshowedhemoglobinresponsesuperioritywithaddondanicopanvsplacebo |